Pfizer–BioNTech COVID-19 vaccine
mRNA vaccine against COVID-19 from BioNTech in cooperation with Pfizer
(Redirected from BNT162b2)
Pfizer–BioNTech COVID-19 vaccine is a COVID-19 vaccine, developed by BioNTech, Pfizer and Fosun Pharmaceutical.
The vaccine is given by injection. It is an RNA vaccine made of nucleoside-modified mRNA which is meant to create spike protein of SARS-CoV-2.[1]
References
change- ↑ Walsh, EE; Frenck, RW Jr; Falsey, AR; Kitchin, N; Absalon, J; Gurtman, A; Lockhart, S; Neuzil, K; Mulligan, MJ; Bailey, R; Swanson, KA; Li, P; Koury, K; Kalina, W; Cooper, D; Fontes-Garfias, C; Shi, PY; Türeci, Ö; Tompkins, KR; Lyke, KE; Raabe, V; Dormitzer, PR; Jansen, KU; Şahin, U; Gruber, WC (2020-10-14). "Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates". The New England Journal of Medicine. 383 (25): 2439–2450. doi:10.1056/NEJMoa2027906. PMC 7583697. PMID 33053279.
